public-health-and-medical-professionals-for-transparency-v-fda—order—20241206
In June 2023 researchers in the UK banned puberty blockers from children outside of clinical research. The ruling is a blow to the radical trans community in England.
The intervention took place to allow researchers to study the procedures and science more behind the controversial intervention on children.
The main objective of the intervention is to alleviate distress associated with gender incongruence & promote the individual’s global functioning and wellbeing. Clinicians are reminded that trans identification may be a transient phase for many youth. /2
— SEGM (@segm_ebm) June 9, 2023
On Wednesday the UK banned puberty blockers for children indefinitely.
Via STV.TV.
The UK Government has said that, following official advice from medical experts, existing emergency measures banning the sale and supply of puberty blockers will be made indefinite.
The Department of Health and Social Care said the Commission on Human Medicines (CHM) had published independent expert advice that there is “currently an unacceptable safety risk in the continued prescription of puberty blockers to children”.
The department said the commission had recommended indefinite restrictions while work is done to ensure the safety of children and young people.
New prescriptions of puberty-blocking medicines and gender-affirming hormones were paused in the wake of Dr Hilary Cass’s review into gender identity services for young people in April.
NHS Greater Glasgow and Clyde, which runs Scotland’s only gender clinic for under-18s, announced it had stopped starting new patients on the treatments in mid-March.
Meanwhile, in America we still have this for a few more weeks.
